Related references
Note: Only part of the references are listed.Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
Elizabeth R. Murray et al.
CELL REPORTS (2022)
TGFβ-Directed Therapeutics: 2020
Beverly A. Teicher
PHARMACOLOGY & THERAPEUTICS (2021)
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
Sara A. Vayrynen et al.
CLINICAL CANCER RESEARCH (2021)
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T. Grunwald et al.
CELL (2021)
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages
Remi Samain et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome
Shannon M. Liudahl et al.
CANCER DISCOVERY (2021)
Estimated Projection of US Cancer Incidence and Death to 2040
Lola Rahib et al.
JAMA NETWORK OPEN (2021)
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton et al.
CANCER CELL (2021)
Tumor restriction by type I collagen opposes tumor- promoting effects of cancer-associated fibroblasts
Sonakshi Bhattacharjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Erin Helms et al.
Cancer Discovery (2020)
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
Remy Nicolle et al.
EBIOMEDICINE (2020)
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
Hemant M. Kocher et al.
NATURE COMMUNICATIONS (2020)
Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
Marc Hilmi et al.
CANCERS (2020)
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Albrecht Neesse et al.
GUT (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
Junya Peng et al.
CELL RESEARCH (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold et al.
LANCET ONCOLOGY (2019)
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma
Cindy Neuzillet et al.
JOURNAL OF PATHOLOGY (2019)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Marc Hilmi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
Francesco Puleo et al.
GASTROENTEROLOGY (2018)
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L. Aung et al.
CLINICAL CANCER RESEARCH (2018)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
Remy Nicolle et al.
CELL REPORTS (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
The multifaceted role of periostin in priming the tumor microenvironments for tumor progression
Dan Cui et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
Hyeon Jeong Oh et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
Miroslava Jurikova et al.
ACTA HISTOCHEMICA (2016)
Loss of Periostin Results in Impaired Regeneration and Pancreatic Atrophy after Cerulein-Induced Pancreatitis
Simone Hausmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
Elisabete F. Carapuca et al.
JOURNAL OF PATHOLOGY (2016)
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
Sebastian R. Nielsen et al.
NATURE CELL BIOLOGY (2016)
Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma
Katarzyna Ratajczak-Wielgomas et al.
ONCOLOGY REPORTS (2016)
TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis
Xing Qin et al.
SCIENTIFIC REPORTS (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer
Lisa Ryner et al.
CLINICAL CANCER RESEARCH (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma
Timothy J. Underwood et al.
JOURNAL OF PATHOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment
Yorihisa Kotobuki et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Triple-negative, Basal Marker-expressing, and High-grade Breast Carcinomas are Characterized by High Lymphatic Vessel Density and the Expression of Podoplanin in Stromal Fibroblasts
Joanna A. Niemiec et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin
Nazihah Bakhtyar et al.
EUROPEAN JOURNAL OF CANCER (2013)
Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
Abasi Ene-Obong et al.
GASTROENTEROLOGY (2013)
Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
Ling-Zhi Hong et al.
ONCOLOGY LETTERS (2013)
StellaTUM: current consensus and discussion on pancreatic stellate cell research
Mert Erkan et al.
GUT (2012)
Periostin activates integrin α5β1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma
Kusumawadee Utispan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Impaired capsule formation of tumors in periostin-null mice
Masashi Shimazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity
Mert Erkan et al.
GASTROENTEROLOGY (2007)
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta(4) integrin and the PI3k pathway
P. Baril et al.
ONCOGENE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Share Paper
